Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1987 3
1988 1
1990 3
1994 1
2000 1
2001 1
2002 1
2003 1
2004 2
2005 1
2006 1
2007 1
2008 2
2009 3
2011 1
2013 1
2015 4
2016 5
2017 4
2018 3
2019 5
2020 1
2021 2
2022 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial.
Paz-Ares L, Dvorkin M, Chen Y, Reinmuth N, Hotta K, Trukhin D, Statsenko G, Hochmair MJ, Özgüroğlu M, Ji JH, Voitko O, Poltoratskiy A, Ponce S, Verderame F, Havel L, Bondarenko I, Kazarnowicz A, Losonczy G, Conev NV, Armstrong J, Byrne N, Shire N, Jiang H, Goldman JW; CASPIAN investigators. Paz-Ares L, et al. Lancet. 2019 Nov 23;394(10212):1929-1939. doi: 10.1016/S0140-6736(19)32222-6. Epub 2019 Oct 4. Lancet. 2019. PMID: 31590988 Clinical Trial.
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.
Powles T, Csőszi T, Özgüroğlu M, Matsubara N, Géczi L, Cheng SY, Fradet Y, Oudard S, Vulsteke C, Morales Barrera R, Fléchon A, Gunduz S, Loriot Y, Rodriguez-Vida A, Mamtani R, Yu EY, Nam K, Imai K, Homet Moreno B, Alva A; KEYNOTE-361 Investigators. Powles T, et al. Lancet Oncol. 2021 Jul;22(7):931-945. doi: 10.1016/S1470-2045(21)00152-2. Epub 2021 May 26. Lancet Oncol. 2021. PMID: 34051178 Clinical Trial.
Durvalumab, with or without tremelimumab, plus platinum-etoposide versus platinum-etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial.
Goldman JW, Dvorkin M, Chen Y, Reinmuth N, Hotta K, Trukhin D, Statsenko G, Hochmair MJ, Özgüroğlu M, Ji JH, Garassino MC, Voitko O, Poltoratskiy A, Ponce S, Verderame F, Havel L, Bondarenko I, Każarnowicz A, Losonczy G, Conev NV, Armstrong J, Byrne N, Thiyagarajah P, Jiang H, Paz-Ares L; CASPIAN investigators. Goldman JW, et al. Lancet Oncol. 2021 Jan;22(1):51-65. doi: 10.1016/S1470-2045(20)30539-8. Epub 2020 Dec 4. Lancet Oncol. 2021. PMID: 33285097 Clinical Trial.
[Ramucirumab - a new anticancer agent].
Telekes A, Deme D. Telekes A, et al. Orv Hetil. 2016 Oct;157(40):1587-1594. doi: 10.1556/650.2016.30535. Orv Hetil. 2016. PMID: 27690622 Review. Hungarian.
[Principles of pharmacotherapy in the elderly].
Telekes A, Deme D. Telekes A, et al. Orv Hetil. 2019 Jun;160(23):896-907. doi: 10.1556/650.2019.31406. Orv Hetil. 2019. PMID: 31155882 Review. Hungarian.
[Prognostic importance of albumin in oncology].
Deme D, Telekes A. Deme D, et al. Among authors: telekes a. Orv Hetil. 2018 Jan;159(3):96-106. doi: 10.1556/650.2018.30885. Orv Hetil. 2018. PMID: 29332415 Review. Hungarian.
Technologies for circulating tumor cell separation from whole blood.
Bankó P, Lee SY, Nagygyörgy V, Zrínyi M, Chae CH, Cho DH, Telekes A. Bankó P, et al. Among authors: telekes a. J Hematol Oncol. 2019 May 14;12(1):48. doi: 10.1186/s13045-019-0735-4. J Hematol Oncol. 2019. PMID: 31088479 Free PMC article. Review.
[Therapeutic options for synovial sarcoma].
Deme D, Telekes A. Deme D, et al. Among authors: telekes a. Orv Hetil. 2015 May 31;156(22):875-80. doi: 10.1556/650.2015.30166. Orv Hetil. 2015. PMID: 26004546 Review. Hungarian.
Site-specific N-glycosylation of HeLa cell glycoproteins.
Turiák L, Sugár S, Ács A, Tóth G, Gömöry Á, Telekes A, Vékey K, Drahos L. Turiák L, et al. Among authors: telekes a. Sci Rep. 2019 Oct 15;9(1):14822. doi: 10.1038/s41598-019-51428-x. Sci Rep. 2019. PMID: 31616032 Free PMC article.
51 results